UGenome AI, a pioneer in genomic platforms to fuel personalized medicine, today announced a partnership with Robust Diagnostics to build out a streamlined antibody biomarker discovery service for early detection biomarker discovery. This partnership helps UGenome AI and Robust Diagnostics drive research and development toward improved clinical outcomes powered by earlier detection biomarkers.

Tucson, AZ & Manassas, VA — August 21, 2025 — UGenome AI, a pioneer in personalized‑genomics software, and Jeeva Clinical Trials, the unified‑or‑modular CTMS provider for decentralized and hybrid studies, today announced a strategic partnership to help sponsors and CROs run faster, more cost‑effective precision‑medicine trials.

April 26, 2024. Pharmacogenomics (PGx), the study of how genetic profiles impact an individual’s responses to medication, has already begun to help healthcare providers (HCPs) optimize care through its capacity to preemptively enhance drug efficacy, minimize adverse side effects, and improve patient experiences. This rapidly growing field marries bioinformatics and pharmacology and represents a transformative new era of precision medicine and highly personalized treatments, one that serves patients by supporting clinicians to better predict therapeutic responses and more accurately optimize drug dosages.

August 2, 2024. Join us for an engaging interview from the Bullpen at Bio 2024 with Zachary Brooks, the founder of UGenome AI. In this conversation, Zachary discusses his experience with five startup companies and reveals the mission of UGenome AI to create SaaS tools for genomic medicine. He emphasizes the importance of having a great team and the company’s focus on human-centric goals. Zachary also shares insights about their current fundraising efforts and aspirations for the future, aiming to improve treatment options and partner with brilliant minds in the field. Tune in for a dose of inspiration and learn about the significance of authentic leadership and collaborative growth.

January 13, 2025. TUCSON A.Z. – UGenome AI, a pioneer in genomic platforms to fuel personalized medicine, today announced a strategic partnership with Jura Health, Inc. to leverage UGenome technology for rare disease patient diagnosis and personalized plans. This collaboration will empower those with rare genetic disorders to learn about their pharmacogenomic profile faster, shorten diagnosis and treatment timelines, and support disease outcomes.

TUCSON, A.Z. – UGenome AI, a pioneer in genomic platforms to fuel personalized medicine, today announced a referral partnership with KonAnbio, to expand each others’ bioinformatics capabilities. This partnership helps UGenome AI and KonAnbio offer a higher throughput and quality of bioinformatics services to their respective partners and clients.

Episode 66 is with Zachary S. Brooks, PhD, EMBA Brooks, CEO of UGenome AI. Zach is anything but conventional. We explore his new book trilogy—Discovering What Awakens You—and dive into his “Human Algorithm,” a powerful framework for living a meaningful life through academics, art, athletics, advocacy, adventure, and purpose. We also unpack Ugenome AI’s groundbreaking work in personalized medicine—helping people understand which medications work best for them through a simple at-home DNA test, potentially saving lives and transforming healthcare. Zach brings ideas that could change how we live and heal. Enjoy!

 On April 28, 2025, UGenome AI team mates Ayse ULGEN, PhD, MGM, Peter Bannister, and Zachary S. Brooks, PhD, EMBA gave a talk to Nottingham Trent University entitled: “UGenome AI’s promise to revolutionize the pharmacogenomics research – ProPEx.”

March 1, 2025. We’re tracking  AniCell Team, UGenome AI and more Biotech companies in Arizona from the F6S community. Biotech is the 33rd most popular industry and market group. If you’re interested in the Biotech market, also check out the top Green Biotechnology, Red Biotechnology, Biodegradable Plastics, Fermentation or Blue Biotechnology companies.

April 14, 2025.

TUCSON A.Z. – UGenome AI, a pioneer in genomic platforms to fuel personalized medicine, today announced a deal with Credtent to use Credtent’s Certified Human-Composed Creation origin badge on UGenome-produced scientific content. Displaying the badge of human written authenticity offers a crucial step forward in transparent, ethical content practices in an era of generative AI.

November 13, 2023. TUCSON, AZ – Precision medicine is often talked about as an ideal, but in practice, it is still an early-stage field. Today, healthcare providers are a step closer to being able to precisely target therapies for those who will benefit most based on their genetic makeup thanks to a new technology developed at the University of Arizona and being advanced into the world through Tucson startup UGenome.